Deutsche Bank AG Makes New $2.32 Million Investment in Heartflow, Inc. $HTFL

Key Points

• Deutsche Bank acquired 79,080 Heartflow shares during the second quarter, valued at approximately $2.32 million and representing 0.09% of the company.
• Analysts maintain a generally positive outlook, with a consensus rating of “Moderate Buy” and an average price target of $43.43, despite the stock opening at $48.10.
• Heartflow reported quarterly revenue of $64.08 million, up 47.7% year over year, and an adjusted loss of $0.07 per share that beat estimates; however, the company remains unprofitable with a negative net margin of 55.82%.

Deutsche Bank AG bought a new position in shares of Heartflow, Inc. (NASDAQ:HTFL - Free Report) during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor bought 79,080 shares of the company's stock, valued at approximately $2,320,000. Deutsche Bank AG owned 0.09% of Heartflow as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors have also recently made changes to their positions in the company. Caitong International Asset Management Co. Ltd bought a new position in Heartflow in the fourth quarter worth $27,000. Russell Investments Group Ltd. bought a new stake in shares of Heartflow during the 4th quarter valued at $45,000. Essential Partners LLC purchased a new stake in shares of Heartflow in the 1st quarter worth about $57,000. Legal & General Group Plc purchased a new stake in shares of Heartflow in the 3rd quarter worth about $59,000. Finally, Strs Ohio bought a new position in shares of Heartflow in the 4th quarter worth about $99,000.

Wall Street Analyst Weigh In

Several equities research analysts recently commented on the stock. Benchmark reissued a "buy" rating on shares of Heartflow in a research note on Friday, August 14th. Morgan Stanley lifted their target price on shares of Heartflow from $35.00 to $40.00 and gave the company an "equal weight" rating in a report on Friday, August 14th. Weiss Ratings raised Heartflow from a "sell (e+)" rating to a "sell (d-)" rating in a research report on Friday, August 7th. Freedom Capital upgraded Heartflow to a "strong-buy" rating in a research note on Tuesday, June 30th. Finally, William Blair started coverage on Heartflow in a research report on Monday, May 4th. They set an "outperform" rating for the company. One analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating, two have issued a Hold rating and one has given a Sell rating to the company's stock. Based on data from MarketBeat.com, Heartflow has an average rating of "Moderate Buy" and a consensus price target of $43.43.

Heartflow Price Performance

Heartflow stock opened at $48.10 on Friday. Heartflow, Inc. has a one year low of $20.13 and a one year high of $51.19. The business's fifty day moving average is $31.97 and its 200 day moving average is $28.93. The stock has a market capitalization of $4.18 billion and a PE ratio of -26.28.

Heartflow (NASDAQ:HTFL - Get Free Report) last issued its earnings results on Thursday, August 13th. The company reported ($0.07) earnings per share for the quarter, topping analysts' consensus estimates of ($0.22) by $0.15. Heartflow had a negative return on equity of 23.52% and a negative net margin of 55.82%.The business had revenue of $64.08 million during the quarter. Heartflow's revenue for the quarter was up 47.7% on a year-over-year basis. As a group, sell-side analysts expect that Heartflow, Inc. will post -0.75 EPS for the current fiscal year.

Insider Buying and Selling

In other Heartflow news, insider Campbell Rogers sold 9,219 shares of the business's stock in a transaction on Monday, August 17th. The shares were sold at an average price of $41.23, for a total transaction of $380,099.37. Following the completion of the sale, the insider directly owned 86,459 shares in the company, valued at approximately $3,564,704.57. The trade was a 9.64% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO John C.M. Farquhar sold 38,900 shares of the stock in a transaction on Wednesday, June 24th. The shares were sold at an average price of $35.00, for a total value of $1,361,500.00. Following the transaction, the chief executive officer directly owned 457,935 shares in the company, valued at $16,027,725. The trade was a 7.83% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last 90 days, insiders have sold 191,271 shares of company stock worth $7,089,136. 7.70% of the stock is owned by insiders.

Heartflow Profile

HeartFlow, Inc NASDAQ: HTFL is a medical technology company that develops non-invasive diagnostic solutions for coronary artery disease. The company's core offering translates coronary CT angiography (CTA) data into a patient-specific, three-dimensional physiological model of the coronary arteries. Using advanced image processing and computational modeling, HeartFlow's analysis estimates fractional flow reserve (FFR) values throughout the coronary tree to identify ischemia-producing lesions without the need for invasive pressure-wire measurements.

HeartFlow's cloud-based service integrates with clinical workflows: clinicians submit coronary CTA images and receive a detailed, color-coded 3D map and report that highlights lesion-specific FFR values and physiological impact.

Want to see what other hedge funds are holding HTFL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Heartflow, Inc. (NASDAQ:HTFL - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.